http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103315980-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6a6f422b091ba12ea61d4adbf1b0e8e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 2013-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_163b18b55a7f91258fe0838f39d4352b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1675afb8db65c904ef995a194e6df924
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecf574cdd3c342af1700cadf9dac79e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b40b8238c9f751e32124e433581a40e8
publicationDate 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103315980-B
titleOfInvention Mucous membrane adhesive polymer drug-loaded pasting film preparation method base on supercutical fluid technology
abstract The invention discloses a mucous membrane adhesive polymer drug-loaded pasting film preparation method base on supercutical fluid technology. A mucous membrane adhesive polymer solution is frozen and dried to get a mucous membrane adhesive polymer pasting film; the mucous membrane adhesive polymer pasting film is disposed in an autoclave of a supercutical fluid drug loaded system; the autoclave is added with medicament in advance, and the medicament has no direct contact with the mucous membrane adhesive polymer pasting film; supercritical carbon dioxide is added and is fully reacted with the mucous membrane adhesive polymer pasting film. Because of the dissolving of the supercritical carbon dioxide to the medicament, the medicament is dipped into the mucous membrane adhesive polymer pasting film, and then the mucous membrane adhesive polymer drug-loaded pasting film is obtained after pressure release. The preparation method has features like mild operation condition, simple operation, steady process, no organic solvent residual, and can be applied for mucous membrane wound treatment and mucous membrane drug supplying.
priorityDate 2013-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457698762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730

Total number of triples: 26.